Evidence map›Paper›PMID 35263766›Full record

ArticleCancer immunology research2022

Circulating Tregs Accumulate in Omental Tumors and Acquire Adipose-Resident Features.

Mingyong Liu, Dmytro Starenki, Christopher D Scharer, Aaron Silva-Sanchez, Patrick A Molina, Jennifer S Pollock, Sara J Cooper, Rebecca C Arend, Alexander F Rosenberg, Troy D Randall and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Mingyong LiuDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-7546-2424
Dmytro StarenkiiRepertoire, Inc, Huntsville, Alabama.
Christopher D ScharerDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.ORCID 0000-0001-7716-8504
Aaron Silva-SanchezDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-1882-2534
Patrick A MolinaSection of Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Jennifer S PollockSection of Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Sara J CooperHudson Alpha Institute for Biotechnology, Huntsville, Alabama.ORCID 0000-0002-9627-0309
Rebecca C ArendDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0003-2108-3426
Alexander F RosenbergDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama.
Troy D Randall *Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0003-0643-0311
Selene Meza-Perez *Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama.
University of Alabama at Birmingham · USEmory University · USHudsonAlpha Institute for Biotechnology · USiRepertoire (United States) · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
Role of microbiota in therapy to ovarian cancerR01CA216234 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RANDALL, TROY D · 2017 to 2021
$2.1M
NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA216234NIAID NIH HHS P30 AI027767
6 · The paper itself

Abstract

Tumors that metastasize in the peritoneal cavity typically end up in the omental adipose tissue, a particularly immune-suppressive environment that includes specialized adipose-resident regulatory T cells (Treg). Tregs rapidly accumulate in the omentum after tumor implantation and potently suppress antitumor immunity. However, it is unclear whether these Tregs are recruited from the circulation or derived from preexisting adipose-resident Tregs by clonal expansion. Here we show that Tregs in tumor-bearing omenta predominantly have thymus-derived characteristics. Moreover, naïve tumor antigen-specific CD4+ T cells fail to differentiate into Tregs in tumor-bearing omenta. In fact, Tregs derived from the pretumor repertoire are sufficient to suppress antitumor immunity and promote tumor growth. However, tumor implantation in the omentum does not promote Treg clonal expansion, but instead leads to increased clonal diversity. Parabiosis experiments show that despite tissue-resident (noncirculating) characteristics of omental Tregs in naïve mice, tumor implantation promotes a rapid influx of circulating Tregs, many of which come from the spleen. Finally, we show that newly recruited Tregs rapidly acquire characteristics of adipose-resident Tregs in tumor-bearing omenta. These data demonstrate that most Tregs in omental tumors are recruited from the circulation and adapt to their environment by altering their homing, transcriptional, and metabolic properties.

Indexed as

NeoplasmsOmentumAdipose TissueAnimalsMiceSpleenT-Lymphocytes, Regulatory

Identifiers

PMID35263766
PMCPMC9064962
OpenAlexW4220995428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.